Disclosed herein is a novel use of CLEC18 in disease prognosis. According to embodiments of the present disclosure, the mRNA or protein level of CLEC18 may serve as an indicator for diagnosing hepatitis B virus (HBV) infection, HBeAg loss and seroconversion, and/or liver fibrosis.
Methods of diagnosing viral infection